Electromed (ELMD) Cash from Financing Activities (2010 - 2026)
Electromed (ELMD) posted quarterly Cash from Financing Activities of -$128000.0 for Q1 2026, up 96.02% year-over-year from -$65298.7 in Q1 2025, and up 95.25% quarter-over-quarter from -$2.7 million in Q4 2025.
Electromed (ELMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Electromed (ELMD) has reported Cash from Financing Activities for 17 consecutive years, with -$128000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 96.02% year-over-year to -$128000.0; the TTM figure through Mar 2026 stood at -$7.5 million (up 9.09% YoY), while the FY2025 annual figure was -$11.9 million, down 33100.0% from the prior year.
- Cash from Financing Activities improved to -$128000.0 in Q1 2026 per ELMD's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $56000.0 in Q1 2024 and bottomed at -$4.5 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged -$994823.5 across 5 years, with a median of -$221000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 225.0% — and 2024, when it sank 15503.45%.
- Electromed's Cash from Financing Activities stood at $8000.0 in 2022, then jumped by 225.0% to $26000.0 in 2023, then tumbled by 2188.46% to -$543000.0 in 2024, then sank by 395.76% to -$2.7 million in 2025, then soared by 95.25% to -$128000.0 in 2026.
- Business Quant data shows ELMD's Cash from Financing Activities at -$128000.0 in Q1 2026, -$2.7 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn | -128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128,000.00 |
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -2.69 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | -3.65 Mn |
| Jun 30, 2025 | -3.65 Mn |
| Mar 31, 2025 | -3.22 Mn |
| Mar 31, 2025 | -3.22 Mn |
| Dec 31, 2024 | -543,000.00 |
| Dec 31, 2024 | -543,000.00 |
| Sep 30, 2024 | -4.47 Mn |
| Sep 30, 2024 | -4.47 Mn |
| Jun 30, 2024 | -75,000.00 |
| Jun 30, 2024 | -75,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |